The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
960
October 27, 1995
View Complete Issue         Table of Contents 2019 
Sevoflurane for General Anesthesia
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Sevoflurane for General Anesthesia
October 27, 1995 (Issue: 960)
Sevoflurane (Ultane - Abbott), a volatile liquid fluorocarbon anesthetic delivered as an inhaled vapor, has been approved by the US Food and Drug Administration for induction and maintenance of general anesthesia. It is being marketed as a rapidly...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Sevoflurane for General Anesthesia
Article code: 960b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.